We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
(-22%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-31.23%
Top 10 Holdings %
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
0.7
quarters
Top 20 Avg Time Held Equity + Options
0.8
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
0.7
quarters
Top 20 Avg Time Held Equity only
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$211M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$189M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$175M |
| 4 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
+$143M |
| 5 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STOR
STORE Capital Corporation
STOR
|
+$414M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$211M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$196M |
| 4 |
SGFY
Signify Health, Inc.
SGFY
|
+$161M |
| 5 |
ONEM
1Life Healthcare
ONEM
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.21% |
| 2 | Healthcare | 21.3% |
| 3 | Technology | 18.64% |
| 4 | Miscellaneous | 15.12% |
| 5 | Industrials | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Getty Realty Corp
GTY
$1.73B
| $1.08M | 0.03% |
+29,952
| New | +$1.05M |
2023 Q1
0 quarters
|
|
377
ON Semiconductor
ON
$29.6B
| $1.03M | 0.02% |
+12,500
| New | +$950K |
2023 Q1
0 quarters
|
|
378
Immunic
IMUX
$108M
| $1.02M | 0.02% |
68,613
+13,624
| +25% | +$253K |
2022 Q1
4 quarters
|
|
|
IPVF
379
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
| $1.01M | 0.02% |
99,050
-561,297
| -85% | -$5.72M |
2021 Q2
7 quarters
|
|
380
RingCentral
RNG
$6.53B
| $1M | 0.02% |
+32,655
| New | +$1.17M |
2023 Q1
0 quarters
|
|
381
Americold
COLD
$3.98B
| $1M | 0.02% |
35,152
-9,656
| -22% | -$288K |
2022 Q4
1 quarter
|
|
382
Rhythm Pharmaceuticals
RYTM
$6.18B
| $1,000K | 0.02% |
+56,050
| New | +$1.41M |
2023 Q1
0 quarters
|
|
383
Rigel Pharmaceuticals
RIGL
$912M
| $1,000K | 0.02% |
75,751
+19,137
| +34% | +$304K |
2022 Q1
4 quarters
|
|
|
THRX
384
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $983K | 0.02% |
+110,715
| New | +$1.09M |
2023 Q1
0 quarters
|
|
385
ARS Pharmaceuticals
SPRY
$416M
| $976K | 0.02% |
+149,915
| New | +$1.15M |
2023 Q1
0 quarters
|
|
386
Disc Medicine
IRON
$2.32B
| $969K | 0.02% |
+45,750
| New | +$1.02M |
2023 Q1
0 quarters
|
|
387
Arvinas
ARVN
$487M
| $966K | 0.02% |
+35,350
| New | +$1.12M |
2023 Q1
0 quarters
|
|
388
Larimar Therapeutics
LRMR
$263M
| $963K | 0.02% |
212,494
+53,082
| +33% | +$277K |
2022 Q4
1 quarter
|
|
|
DISH
389
PUT
DELISTED
DISH Network Corp.
DISH
| $963K | 0.02% |
126,400
+63,800
| +102% | +$804K |
2021 Q2
7 quarters
|
|
|
HWEL
390
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
| $959K | 0.02% |
94,525
| – | – |
2021 Q4
5 quarters
|
|
391
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $956K | 0.02% |
92,674
| – | – |
2022 Q1
4 quarters
|
|
392
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
| $956K | 0.02% |
92,674
| – | – |
2022 Q2
3 quarters
|
|
393
Uber
UBER
$146B
| $946K | 0.02% |
+29,830
| New | +$946K |
2023 Q1
0 quarters
|
|
394
DELISTED
iTeos Therapeutics
ITOS
| $943K | 0.02% |
69,300
+7,300
| +12% | +$131K |
2022 Q1
4 quarters
|
|
|
MNK
395
DELISTED
Mallinckrodt plc
MNK
| $943K | 0.02% |
129,376
| – | – |
2022 Q4
1 quarter
|
|
396
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $936K | 0.02% |
+440,000
| New | +$176M |
2023 Q1
0 quarters
|
|
|
ACAH
397
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
| $933K | 0.02% |
92,674
| – | – |
2021 Q4
5 quarters
|
|
398
Alexandria Real Estate Equities
ARE
$7.59B
| $914K | 0.02% |
7,280
-16,792
| -70% | -$2.47M |
2022 Q1
4 quarters
|
|
399
Amazon
AMZN
$2.8T
| $914K | 0.02% |
+8,847
| New | +$855K |
2023 Q1
0 quarters
|
|
400
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $912K | 0.02% |
242,026
+51,525
| +27% | +$203K |
2022 Q3
2 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2023 Portfolio in Review
As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.
- UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
- UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
- UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
- UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
- UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
- UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.
Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.